Status:
WITHDRAWN
Endogenous Retroviruses in Acute Myeloid Leukemia
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Leukemia, Myeloid
Eligibility:
All Genders
18+ years
Brief Summary
Allogeneic hematopoietic stem cell transplantation (HSCT) is the only curative therapy for numerous malignant hematologic diseases. Despite recent advances in the field, relapse rates are still high a...
Eligibility Criteria
Inclusion
- Acute myeloid leukemia (all subtypes)
- Stem cell transplantation indication
- Non opposition to the study
Exclusion
- \- Intensive care unit at diagnosis
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 6 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04406207
Start Date
June 1 2020
End Date
January 6 2022
Last Update
August 22 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.